Glasgow-Imrie Score Calculator

Glasgow-Imrie Score Calculator for Gastroenterology. The threshold is a score of 3 or more (out of 8) predicting severe acute pancreatitis; a score of 0 to 2 predicts a mild, self-limiting course. In the original prospective validation of 405 episodes, 31% of patients with 3 or more factors developed severe disease versus only 8% of those with fewer than 3, and severity was correctly classified in roughly 72-79% overall. The score is therefore best used as an early triage signal: a result of 3 or more should prompt closer monitoring, consideration of HDU/ICU care, and early senior review, rather than being read as a fixed mortality probability. A low score does not license discharge, since deterioration can still occur.

How this calculator works

The Glasgow-Imrie score stratifies severity of acute pancreatitis using eight objective parameters measured within the first 48 hours of admission, remembered by the mnemonic PANCREAS: PaO2 below 8 kPa (60 mmHg), Age over 55 years, Neutrophils/white cell count above 15 x 10^9/L, Calcium below 2.0 mmol/L (8 mg/dL), Renal function with urea above 16 mmol/L (BUN above ~45 mg/dL), Enzymes with LDH above 600 IU/L (and AST/ALT above 200 IU/L in the original nine-factor version), Albumin below 32 g/L, and Sugar (glucose) above 10 mmol/L (180 mg/dL). Each criterion present scores one point. The eight-factor modified version derived by Blamey and colleagues in 1984 dropped the original serum transaminase criterion, which had not independently predicted severity. Unlike the pancreatitis-etiology-specific origins, the modified score applies equally to gallstone and alcohol-related disease.

When to use this calculator

Use it in the first 48 hours after admission for acute pancreatitis to flag patients likely to develop severe disease who warrant HDU/ICU-level monitoring, aggressive fluids, and early specialist input. It requires a full 48-hour window, so it cannot be applied at the moment of presentation the way an admission-only tool (such as BISAP or the harmless acute pancreatitis score) can. It is not a diagnostic test for pancreatitis and does not replace CT severity indices, which assess necrosis later in the course; it also has not been validated for pediatric or post-ERCP pancreatitis populations.

Inputs used

  • Age
  • White blood cell count
  • Glucose
  • Urea
  • PaO2
  • Calcium
  • Albumin
  • LDH
  • AST

Clinical interpretation

The threshold is a score of 3 or more (out of 8) predicting severe acute pancreatitis; a score of 0 to 2 predicts a mild, self-limiting course. In the original prospective validation of 405 episodes, 31% of patients with 3 or more factors developed severe disease versus only 8% of those with fewer than 3, and severity was correctly classified in roughly 72-79% overall. The score is therefore best used as an early triage signal: a result of 3 or more should prompt closer monitoring, consideration of HDU/ICU care, and early senior review, rather than being read as a fixed mortality probability. A low score does not license discharge, since deterioration can still occur.

Worked example

A 62-year-old man 48 hours into an admission for gallstone pancreatitis has PaO2 7.5 kPa (1 point), age 62 (1 point), WCC 18 x 10^9/L (1 point), corrected calcium 1.9 mmol/L (1 point), urea 14 mmol/L (0), LDH 520 IU/L (0), albumin 30 g/L (1 point), and glucose 12 mmol/L (1 point). Total = 6. A score of 3 or more predicts severe pancreatitis, so this patient should be escalated to critical-care-level monitoring with attention to hypocalcemia, hypoxemia, and fluid resuscitation.

Limitations and safety notes

The score requires a full battery of labs including an arterial blood gas and cannot be completed until 48 hours have elapsed, delaying its use at first contact. Its positive predictive value is modest (only about a third of high-scoring patients actually develop severe disease), so it over-triages. It was derived and validated in adult gallstone and alcohol-related pancreatitis and has not been established in children, in hypertriglyceridemic or post-ERCP pancreatitis, or against modern revised Atlanta severity definitions. Transient hyperglycemia, pre-existing renal impairment, or chronic hypoalbuminemia can falsely elevate individual components.

Frequently asked questions

How does the Glasgow-Imrie score differ from Ranson's criteria?

Both are 48-hour scores, but Ranson uses different parameters and separate criteria for gallstone versus alcoholic pancreatitis, whereas the modified Glasgow-Imrie uses a single eight-factor set that applies to both etiologies, making it simpler at the bedside. Glasgow requires an arterial blood gas but omits Ranson's fluid-sequestration and base-deficit measures.

Is it the 8-factor or 9-factor version that is used today?

The 8-factor modified version (Blamey 1984) is standard. The original 1978 Imrie score included serum transaminase (AST) as a ninth factor, but this parameter did not independently predict severity in prospective testing and was removed.

What does a score of 3 mean for my patient?

A score of 3 or more predicts severe acute pancreatitis and should trigger escalation to closer or critical-care monitoring, aggressive resuscitation, and early specialist involvement. It is a risk signal, not a certainty; in validation data about 31% of such patients went on to severe disease.

Can I calculate it on admission?

No. Several parameters (such as the trajectory of urea, calcium, and PaO2) are meant to be assessed across the first 48 hours, so the definitive score is completed at 48 hours. For an admission-time estimate, tools like BISAP or APACHE II are more appropriate.

Does a low score mean the patient can be discharged?

Not by itself. A score under 3 predicts a milder course but does not exclude later deterioration, local complications, or organ failure, so clinical monitoring and serial assessment remain necessary.

References

  • Blamey SL, Imrie CW, O'Neill J, Gilmour WH, Carter DC. Prognostic factors in acute pancreatitis. Gut. 1984. PMID: 6510766.
  • Imrie CW, Benjamin IS, Ferguson JC, McKay AJ, Mackenzie I, O'Neill J, Blumgart LH. A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis. Br J Surg. 1978. PMID: 348250.
  • Working Group IAP/APA Acute Pancreatitis Guidelines. IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology. 2013. PMID: 24054878.

Editorial review and citation methodology

Reviewed by the Quick Medical Calculator Editorial Team. Last reviewed: April 28, 2026. The review checks calculator inputs, intended population, interpretation, limitations, and source alignment.

  • Prefer original validation studies for scoring systems and prediction tools.
  • Use current specialty society guidance, transplant allocation policy, public health guidance, or regulator resources when they govern clinical use.
  • Include limitations and safety notes when a calculator is population-specific, context-dependent, or unsuitable as a standalone decision tool.

Related reviewed calculators